Tag: delcath
Delcath Systems announces additional funding for Hepzato Kit FDA approval
Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, has announced that it raised approximately...
Delcath Systems announces updated results from CHOPIN phase 1b trial
Delcath Systems has shared in a press release the publication of updated results from the phase 1b CHOPIN Trial, conducted at Leiden University Medical...
Results of single-centre study of Chemosat hepatic delivery system published in...
Delcath Systems announced the publication of a retrospective analysis of patients who underwent a percutaneous hepatic perfusion procedure (PHP) with Chemosat for the treatment...
Results of a multicentre study of Chemosat hepatic delivery system published...
Delcath Systems has announced the publication of a retrospective analysis of patients who underwent a percutaneous hepatic perfusion procedure (PHP) with Chemosat at three...
